BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35946336)

  • 1. Emotion and contralateral prophylactic mastectomy: A prospective study into surgical decision-making.
    Krasniak PJ; Nguyen M; Janse S; Phommasathit C; Clevenger K; Renshaw S; Agnese DM; Padamsee TJ; Lee CN
    Psychooncology; 2022 Oct; 31(10):1711-1718. PubMed ID: 35946336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
    Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
    JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.
    D'Agostino TA; Brewster AM; Peterson SK; Bedrosian I; Parker PA
    Transl Behav Med; 2020 May; 10(2):347-354. PubMed ID: 30561744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
    Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
    Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
    Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
    JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations.
    de Silva TS; Russell VR; Henry FP; Thiruchelvam PTR; Hadjiminas DJ; Al-Mufti R; Hogben RK; Hunter J; Wood S; Jallali N; Leff DR
    Ann Surg Oncol; 2018 Oct; 25(10):3057-3063. PubMed ID: 30019305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
    Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Sure: a randomized pilot trial of an interactive web-based decision support aid versus usual care in average-risk breast cancer patients considering contralateral prophylactic mastectomy.
    Manne SL; Smith BL; Frederick S; Mitarotondo A; Kashy DA; Kirstein LJ
    Transl Behav Med; 2020 May; 10(2):355-363. PubMed ID: 30608607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operating on Anxiety: Negative Affect toward Breast Cancer and Choosing Contralateral Prophylactic Mastectomy.
    Silverstein MC; Lee CN; Scherer LD; Phommasathit C; Merrill AL; Peters E
    Med Decis Making; 2023 Feb; 43(2):152-163. PubMed ID: 36059240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
    Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
    Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.
    Katz SJ; Janz NK; Abrahamse P; Wallner LP; Hawley ST; An LC; Ward KC; Hamilton AS; Morrow M; Jagsi R
    JAMA Surg; 2017 Jul; 152(7):658-664. PubMed ID: 28384687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
    Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
    Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-making experiences of breast cancer patients related to contralateral prophylactic mastectomy-a systematic meta-synthesis of qualitative studies.
    Zhao B; Yi M; Lyu H; Zhang X; Liu Y; Song X
    Support Care Cancer; 2023 Mar; 31(4):214. PubMed ID: 36918480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study.
    Squires JE; Stacey D; Coughlin M; Greenough M; Roberts A; Dorrance K; Clemons M; Caudrelier JM; Graham ID; Zhang J; Varin MD; Arnaout A
    Curr Oncol; 2019 Apr; 26(2):137-148. PubMed ID: 31043816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
    Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES
    Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.